Another group also reported results from α-GalCer-loaded B cell lymphoma (Eμ-myc tumor) combined with an agonistic antibody targeting 4-1BB (CD137) [156]. The gene discussed is TNFRSF9; the disease is B-cell non-Hodgkin lymphoma.